Louis G. Lange, Director at Audentes Therapeutics, Inc. (BOLD), sold 20,755 shares at $32.15 ($667K) on 2019-09-23, disclosed to the SEC on 2019-09-25.
Open-market sale of $667k BOLD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.15 | 9,755 | $314K | 47.0% |
| 2 | $32.15 | 9,755 | $314K | 47.0% |
| 3 | $32.18 | 1,000 | $32K | 4.8% |
| 4 | $32.66 | 245 | $8K | 1.2% |
| Total | $32.16 avg | 20,755 | $667K | 100% |
| Filing → |
| NAMS | BUY | 2024-02-21 | $95K | — | Filing → |
| BOLD | SELL | 2019-12-27 | $656K | — | Filing → |
| BOLD | SELL | 2019-06-26 | $1.5M | — | Filing → |